Odyssey Health, Inc. ODYY
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 913.00K | 938.40K | 769.90K | 744.60K | 1.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 913.00K | 938.40K | 769.90K | 744.60K | 1.02M |
| Operating Income | -913.00K | -938.40K | -769.90K | -744.60K | -1.02M |
| Income Before Tax | -5.73M | -3.57M | -4.59M | -1.21M | -1.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.73 | -3.57 | -4.59 | -1.21 | -1.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.73M | -3.57M | -4.59M | -1.21M | -1.74M |
| EBIT | -913.00K | -938.40K | -769.90K | -744.60K | -1.02M |
| EBITDA | -- | -155.30K | -284.00K | -440.20K | -1.02M |
| EPS Basic | -0.05 | -0.03 | -0.04 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.04 | -0.02 | -0.03 | -0.01 | -0.01 |
| EPS Diluted | -0.05 | -0.04 | -0.05 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.04 | -0.02 | -0.03 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 433.32M | 426.63M | 423.31M | 420.17M | 418.84M |
| Average Diluted Shares Outstanding | 511.96M | 505.28M | 423.31M | 420.17M | 418.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |